Asthma therapy for the 21st century.
Rogers
D F
DF
Imperial College School of Medicine, National Heart & Lung Institute, London, UK.
Giembycz
M A
MA
D000318:Adrenergic beta-Agonists / Q000627:therapeutic use; D018927:Anti-Asthmatic Agents / Q000627:therapeutic use*; D001249:Asthma / Q000097:blood / Q000188:drug therapy*; D001993:Bronchodilator Agents / Q000627:therapeutic use*; D015815:Cell Adhesion Molecules / Q000627:therapeutic use; D004804:Eosinophils / Q000187:drug effects / Q000502:physiology; D005938:Glucocorticoids / Q000627:therapeutic use; D010726:Phosphodiesterase Inhibitors / Q000627:therapeutic use; D011379:Prognosis; D013601:T-Lymphocytes / Q000187:drug effects / Q000502:physiology; D013806:Theophylline / Q000627:therapeutic use; D014158:Transcription, Genetic / Q000187:drug effects
D000318:Adrenergic beta-Agonists; D018927:Anti-Asthmatic Agents; D001993:Bronchodilator Agents; D015815:Cell Adhesion Molecules; D005938:Glucocorticoids; D010726:Phosphodiesterase Inhibitors; D013806:Theophylline